Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...

DexCom is scheduled to announce its fiscal third-quarter earnings later this month, and analysts project a double-digit ...

DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...

Medtech leaders with varying degrees of experience have offered a range of advice in terms of leadership at the helm of a ...

DexCom, Inc. (NASDAQ:DXCM) is one of the Best Long Term Growth Stocks to Buy Now. On September 19, William Blair analyst ...

A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of ...

Connacht's Sean Naughton cannot convert Mack Hansen's 79th-minute try as the western province are beaten 28-27 by the Bulls at Dexcom Stadium.

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

How is QQQ stock faring? The Invesco QQQ ETF has declined 1.14% over the past five days but is up 17.4% year-to-date. What ...

In other recent news, DexCom has been the focus of various analyst reports and market reactions regarding its G7 continuous glucose monitoring device. UBS maintained its Buy rating for DexCom, setting ...

Fintel reports that on October 1, 2025, Goldman Sachs maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 58.14% Upside As of September 29, 2025, ...